Trypanosoma brucei Invariant Surface Glycoprotein 75 Is an Immunoglobulin Fc Receptor Inhibiting Complement Activation and Antibody-Mediated Cellular Phagocytosis.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
23 Feb 2024
Historique:
received: 12 12 2023
accepted: 05 02 2024
medline: 23 2 2024
pubmed: 23 2 2024
entrez: 23 2 2024
Statut: aheadofprint

Résumé

Various subspecies of the unicellular parasite Trypanosoma brucei cause sleeping sickness, a neglected tropical disease affecting millions of individuals and domestic animals. Immune evasion mechanisms play a pivotal role in parasite survival within the host and enable the parasite to establish a chronic infection. In particular, the rapid switching of variant surface glycoproteins covering a large proportion of the parasite's surface enables the parasite to avoid clearance by the adaptive immune system of the host. In this article, we present the crystal structure and discover an immune-evasive function of the extracellular region of the T. brucei invariant surface gp75 (ISG75). Structural analysis determined that the ISG75 ectodomain is organized as a globular head domain and a long slender coiled-coil domain. Subsequent ligand screening and binding analysis determined that the head domain of ISG75 confers interaction with the Fc region of all subclasses of human IgG. Importantly, the ISG75-IgG interaction strongly inhibits both activation of the classical complement pathway and Ab-dependent cellular phagocytosis by competing with C1q and host cell FcγR CD32. Our data reveal a novel immune evasion mechanism of T. brucei, with ISG75 able to inactivate the activities of Abs recognizing the parasite surface proteins.

Identifiants

pubmed: 38391367
pii: 266709
doi: 10.4049/jimmunol.2300862
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Aarhus Universitets Forskningsfond (Aarhus University Research Foundation)
Organisme : Novo Nordisk Fonden (NNF)
ID : NNF18OC0032724
Organisme : Novo Nordisk Fonden (NNF)
ID : NNF21OC0067647
Organisme : Carlsbergfondet (Carlsberg Foundation)

Informations de copyright

Copyright © 2024 by The American Association of Immunologists, Inc.

Auteurs

Jakob Hauge Mikkelsen (JH)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Kristian Stødkilde (K)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Maria Pauladòttir Jensen (MP)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Annette Gudmann Hansen (AG)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Qi Wu (Q)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Josefine Lorentzen (J)

Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

Jonas Heilskov Graversen (JH)

Department of Cancer and Inflammation, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.

Gregers Rom Andersen (GR)

Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

Robert Andrew Fenton (RA)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Anders Etzerodt (A)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Steffen Thiel (S)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Christian Brix Folsted Andersen (CBF)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Classifications MeSH